Prevention of diabetes-induced microangiopathy by human tissue kallikrein gene transfer

Circulation

Volumn 106, Issue 8, 2002, Pages 993-999

  Emanueli, Costanza ^a   Salis, Maria B ^a   Pinna, Alessandra ^a   Stacca, Tiziana ^a   Milia, Anna F ^a   Spano, Alessandra ^a   Chao, Julie ^a   Chao, Lee ^a   Sciola, Luigi ^a   Madeddu, Paolo ^a  

^a NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

Author keywords

Angiogenesis; Apoptosis; Diabetes mellitus; Gene therapy; Microangiopathy

Indexed keywords

ADENOVIRUS VECTOR; TISSUE KALLIKREIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DNA VECTOR; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; GENE THERAPY; GENE TRANSFER; HEMODYNAMICS; HINDLIMB; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; STREPTOZOCIN DIABETES;

ANIMALS; APOPTOSIS; COMBINED MODALITY THERAPY; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; GENE THERAPY; HINDLIMB; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ISCHEMIA; KINETICS; MALE; MICE; MICROCIRCULATION; MUSCLE, SKELETAL; NUCLEOTIDES, CYCLIC; TISSUE KALLIKREINS;

EID: 0037143686     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000027104.33206.C8     Document Type: Article

References (31)

1. Diabetes and cardiovascular disease: The Framingham study
2. Epidemiology and cost of inpatient care of peripheral vascular disease, infection, neuropathy and ulceration in diabetes
3. The contribution of non-insulin-dependent diabetes to lower-extremity amputation in the community
4. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF
5. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: Molecular mechanisms of delayed angiogenesis in diabetes
6. Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice
7. Adenovirus-mediated human tissue kallikrein gene delivery induces angiogenesis in normoperfused skeletal muscle
8. Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in a mouse model of hindlimb ischemia
9. Targeting kinin receptors for the treatment of tissue ischemia
10. Targeting kinin B1 receptor for therapeutic neovascularization
11. The bradykinin/B1 receptor promotes angiogenesis by up-regulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway
12. Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dog skeletal muscle and rat L6 myoblasts
13. 2 receptor knockout mice
14. Role of the B2 receptor of bradykinin in insulin sensitivity
15. Myocardial expression of rat bradykinin receptors and two tissue kallikrein genes in experimental diabetes
16. Induction of renal kallikrein and renin gene expression by insulin and IGF-I in the diabetic rat
17. Decreased urinary kallikrein with hyperglycemia in patients with short-term insulin-dependent diabetes mellitus
18. Reversal of angiogenic growth factor upregulation by revascularization of lower limb ischemia
19. Systemic and portal vein delivery of human kallikrein gene reduces blood pressure in hypertensive rats
20. Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene
21. Impaired NO-dependent dilation of skeletal muscle arterioles in hypertensive diabetic obese Zucker rats
22. Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion
23. Rapid transactivation of the vascular endothelial growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor contributes to endothelial nitric-oxide synthase activation in cardiac capillary endothelial cells
24. Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation
25. Activation of nitric oxide synthase in endothelial cells via Akt-dependent phosphorylation
26. Nitric oxide induces and inhibits apoptosis through different pathways
27. Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: Effects of angiotensin-converting enzyme inhibitors
28. The cellular and molecular mechanisms of diabetic complications
29. Adenovirus-mediated kallikrein gene delivery reduces aortic thickening and stroke-induced death rate in Dahl-sensitive rats
30. Proangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway
31. Angiotensin AT(1) receptor signalling modulates reparative angiogenesis induced by limb ischaemia